Gastric Adenocarcinoma

• CLINICAL_TRIALS trial_result · 2013-12-04
  Clinical Trial Update: Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resection [Phase 2]

  A Phase II clinical trial evaluating catumaxomab in gastric cancer patients who received neoadjuvant chemotherapy and curative resection has…

• CLINICAL_TRIALS trial_result · 2013-07-02
  Clinical Trial Update: FR901228 in Treating Patients With Refractory Stomach Cancer or Gastroesophageal Junction Cancer [Phase 2]

  A Phase 2 trial of FR901228 in patients with refractory stomach cancer or gastroesophageal junction cancer was terminated.

• CLINICAL_TRIALS trial_result · 2013-06-04
  Clinical Trial Update: Concurrent Induction Chemoimmunotherapy With Epirubicine, Oxaliplatin, Capecitabine and Panitumumab in KRAs Wild-type, Resectable Type II Gastric Adenocarcinoma [Phase 2]

  A Phase 2 trial assessing concurrent induction chemoimmunotherapy with epirubicin, oxaliplatin, capecitabine, and panitumumab in KRAS wild-t…

• CLINICAL_TRIALS trial_result · 2013-06-04
  Clinical Trial Update: Docetaxel and S1 (DS) Versus S1 and Cisplatin (SP) in Curatively Resected Stage IIIB/IV Gastric Cancer [Phase 3]

  Phase 3 trial comparing docetaxel plus S-1 versus S-1 plus cisplatin in curatively resected stage IIIB/IV gastric cancer. The current status…

• CLINICAL_TRIALS trial_result · 2013-02-20
  Clinical Trial Update: Efficacy and Safety Study of Combination Therapy With Docetaxel-oxaliplatin-capecitabine in Patients With Advanced Gastric Adenocarcinoma and Intermediate General Status [Phase 2]

  This Phase 2 trial evaluates the efficacy and safety of a docetaxel-oxaliplatin-capecitabine combination in patients with advanced gastric a…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2012-12-10
  Clinical Trial Update: Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers [Phase 2]

  Phase 2 trial of irinotecan/cisplatin with potentially curative surgery (with or without floxuridine) followed by capecitabine for gastric a…

• CLINICAL_TRIALS trial_result · 2012-07-17
  Clinical Trial Update: Efficacy and Safety Study of ABI-007 Plus Capecitabine as First-line Chemotherapy for Advanced Gastric Cancer Patients [Phase 2]

  Phase 2 trial evaluating ABI-007 (nab-paclitaxel) plus capecitabine as first-line chemotherapy for advanced gastric cancer, with an efficacy…

• CLINICAL_TRIALS research · 2012-04-24
  Clinical Trial Update: SOX Regimen as Neoadjuvant Chemotherapy for AJCC Stage II-III Gastric Cancer [Phase 3]

  Phase 3 clinical trial evaluating the SOX regimen (S-1 plus oxaliplatin) as neoadjuvant chemotherapy for AJCC stage II-III gastric cancer.

• CLINICAL_TRIALS trial_result · 2012-03-28
  Clinical Trial Update: Efficacy and Safety Study of a Modified SOX Regimen in First-Line Treatment of Unresectable Gastric Adenocarcinoma [Phase 2]

  Phase 2 trial assessing efficacy and safety of a modified S-1 plus oxaliplatin (SOX) regimen as first-line treatment for unresectable gastri…

• CLINICAL_TRIALS trial_result · 2012-01-19
  Clinical Trial Update: A Study of Bevacizumab in Combination With Capecitabine and Cisplatin as First-line Therapy in Patients With Advanced Gastric Cancer [Phase 3]

  Phase 3 trial evaluating bevacizumab added to capecitabine and cisplatin as first-line therapy for advanced gastric cancer; results from the…

• CLINICAL_TRIALS trial_result · 2011-01-14
  Clinical Trial Update: Efficacy and Safety of Sunitinib in Metastatic Gastric Cancer [Phase 2]

  A Phase 2 trial evaluating the efficacy and safety of sunitinib in metastatic gastric cancer (gastric adenocarcinoma) has completed with res…

• CLINICAL_TRIALS research · 2008-10-21
  Clinical Trial Update: Phase II Study of Neoadjuvant Taxotere, Cisplatin, and 5-Fluorouracil in Patients With Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 2]

  Phase II neoadjuvant trial of docetaxel (Taxotere), cisplatin, and 5-fluorouracil for gastric or gastroesophageal junction adenocarcinoma; n…

• CLINICAL_TRIALS trial_result · 2007-12-31
  Clinical Trial Update: Phase II Trial of Gleevec and Taxotere as a Combined Regimen for Advanced Gastric Adenocarcinoma [Phase 2]

  Phase II trial evaluating a combination of imatinib (Gleevec) and docetaxel (Taxotere) for advanced gastric adenocarcinoma has been terminat…

• CLINICAL_TRIALS trial_result · 2007-10-26
  Clinical Trial Update: Safety and Efficacy Study With Catumaxomab in Patients After Curative Resection of a Gastric Adenocarcinoma [Phase 2]

  Phase 2 study evaluating the safety and efficacy of Catumaxomab in patients after curative resection of gastric adenocarcinoma has completed…